000			02055nam a2200481 a 4500
005			20250914143408.0
008			060426s2004 xxu 000 0 eng
020			_a0309091284 (pbk.) _cRM175.92
039		9	_a200605171535 _bjufri _c200604261705 _dbalqis _y04-26-2006 _zbalqis
060			_aWM270 _b.N5327 2004 9HUKM
090			_aWM270.N5327 2004 9HUKM
245	0	0	_aNew treatments for addiction : _bbehavioral, ethical, legal, and social questions
260			_aWashington, D. C. : _bThe National Academies Press, _c2004
300			_axiv, 306 p. : _bill. ; _c23 cm.
504			_aReferences (p. 54-60)
505	0		_aIntroduction and background -- Clinical trials -- Treatment, financing, and costs -- Behavioral responses and consent
530			_aAlso issued online
610		2	_aNational Institute on Drug Abuse
650		2	_aSubstance-Related Disorders _xtherapy
650		2	_aSubstance-Related Disorders _xpsychology
650		2	_aImmunotherapy _xethics
650		2	_aImmunotherapy _xlegislation and jurisprudence
650		2	_aDelayed-Action Preparations _xtherapeutic use
650		2	_aClinical trials
650		2	_aHealth Care Costs
650		2	_aHealth policy
650		2	_aInformed Consent
651		2	_aUnited States
700	1		_aHarwood, Henrick J.
700	1		_aMyers, Tracy G.
710	2		_aCommittee on Immunotherapies and Sustained-Release Formulations for Treating Drug Addiction
710	2		_aNational Research Council (U.S.) _bBoard on Behavioral, Cognitive, and Sensory Sciences
710	2		_aInstitute of Medicine (U.S.) _bBoard on Health Promotion and Disease Prevention
710	2		_aInstitute of Medicine (U.S.) _bBoard on Neuroscience and Behavioral Health
856	4		_ahttp://www.nap.edu/books/0309091284/html/
907			_a.b13719634 _b2019-11-12 _c2019-11-12
942			_c01 _n0 _kWM270.N5327 2004 9HUKM
914			_avtls003326161
990			_aNorhayati/jufri
991			_aJabatan Kebajikan Perubatan, HUKM
998			_ah _b2006-01-04 _cm _da _feng _gxxu _y0 _z.b13719634
999			_c370468 _d370468